Page 43 - Mobile Android News Today

The FDA has issued a Complete Response Letter for the New Drug Application for risperidone extended-release injectable for subcutaneous use, a schizophrenia treatment, Teva Pharmaceuticals and MedinCell announced in a statement.The FDA states on its website that it will send a Complete Response Letter if the agency determines it will not approve the application in its present form.

Plinabulin demonstrated similar efficacy to pegfilgrastim for the prevention of chemotherapy-induced neutropenia, according to results of a randomized phase 3 study published in JAMA Network Open.“Plinabulin, a nongranulocyte colony-stimulating factor agent that has anticancer properties, was shown to reduce the incidence of chemotherapy-induced neutropenia in a phase 2 clinical trial

With the number of cataract surgeries expected to increase in the coming years, young ophthalmologists need to take steps to prepare themselves for higher surgical volume, according to a presentation at Real World Ophthalmology. David Felsted, DO, shared pointers for jumping into a high-volume situation.

Healio Rheumatology | This month, we are so lucky to have such an extraordinary panel of experts in the field of rheumatoid arthritis — Daniel Aletaha, MD, MSc; Stanley Cohen, MD; Bryant R. England, MD, PhD; Roy Fleischmann, MD; and Liana Fraenkel, MD, MPH — debate the merits of remission vs. low disease activity as the desired target in the therapy of rheumatoid arthritis.Selecting too rigid a criterion

Nephrology News and Issues | Nurses who attend the American Nephrology Nurses Association Annual Symposium in May will have an opportunity to recharge their enthusiasm for kidney care, organizers told Nephrology News & Issues.“The past 2 years have been challenging for all nurses, nephrology nurses included,” Tamara Kear, PhD, RN, CNN, FAAN, executive director of ANNA, told Nephrology News & Issues.

In this video, Gary W. Herschman, JD, discusses the increase in physician transactions with private equity firms and four major reasons for this trend.“The first driver of this is the ability to monetize the true value of a physician practice,” Herschman, an attorney in the health care and life sciences practice of Epstein Becker Green, told Healio.

Healio Rheumatology | Treating to target has, since the dawn of targeted biologic and non-biologic disease modifying anti-rheumatic drugs, permeated every aspect of rheumatology care.Defining those treatment targets, however, is an inexact science.

SEATTLE — Although advancements have been made in immune checkpoint inhibitors, tumors such as glioblastoma present a roadblock to successful therapy, according to a presenter at the 2022 American Academy of Neurology annual meeting.“Inhibitors have really revolutionized oncology in the past 10 years with various different indications,” Priya Kumthekar, MD, associate professor

Starting abortion medication before knowing the location of an unwanted pregnancy was associated with shorter time to abortion and quicker exclusion of ectopic pregnancy, according to a retrospective cohort study in Obstetrics & Gynecology.

A federal grand jury on April 15 acquitted DaVita Inc. and its former CEO Kent Thiry of three counts of conspiracy based on coordinating agreements Thiry and the company arranged with three other companies not to solicit certain employees.